... in the U.S. will be diagnosed with liver cancer, and over 18,000 liver cancer patients will succumb to the disease ... on 9 final recommendations for transplantation of liver cancer patients: 1. Additional priority should ...
... in Tampa, Fla. "This is encouraging news for liver cancer patients, especially those who also have blockage in the portal vein ... -90 as a potential treatment option to liver cancer patients," he added. About 18,500 ...
A combination of an oral drug, called sorafenib, and a method for injecting microbeads of chemotherapy directly into tumors has been proven safe for liver cancer patients and may improve [...]
... York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent ... , and is currently being evaluated in patients with other cancers. Some 40 percent of liver cancers (and up to 80 percent in Asia ...
... (www.interscience.wiley.com). For patients with liver cancer (also known as hepatocellular carcinoma), transplantation ... 2007, the researchers enrolled 61 liver cancer patients whose tumor stage exceeded ...
... tissues and applied it to samples from more than 300 liver cancer patients. Their work uncovered a striking pattern — a characteristic signature of more than 180 active and inactive ...
... that oncologists will be able to use this information to determine which liver cancer patients would likely suffer recurrence ... step is to analyze samples from more patients to confirm findings in liver cancer. He said he sees ...
... to determine its association with clinical outcomes of liver cancer patients who undergo transplantation. The findings show ... . They conclude that Capn4 has the potential to be used as a novel prognostic marker for liver cancer patients, and as a target for therapy ...
... levels but also promotes fat breakdown in the liver. Cancer patients, too, might benefit from these findings. Many of them suffer from what is called tumor ...
... (HCC), in the U.S. They included 420 patients with liver cancer and 1,104 healthy controls ... and hepatitis C. About 15 percent of the liver cancer patients had a history of thyroid disease, compared ...
... ratio in predicting colorectal liver metastases in liver cancer patients undergoing transplantation. Dr ... risk for tumor recurrence and death in liver cancer patients receiving transplantation. Low-Dose ...
... as a microRNA, may help physicians identify liver cancer patients who, in spite of their poor prognosis, could respond well to treatment with a biological agent called ...
... from China retrospectively evaluated 5311 liver cancer patients who received resection between October 1999 and December 2003. Of these, 429 (8.1 ...
... hepatocellular carcinoma (liver cancer) significantly increases survival rates for this patient population. Results ... recipients, confirming the specificity of its beneficial impact to cancer patients. "Of all protocols, sirolimus-based immunosuppression ...
... -- the use of intra-arterial yttrium-90 microspheres for liver cancer (also known as hepatocellular carcinoma) -- shows promise in prolonging life for many patients ...
